Adbiotech Co (XKRX:179530) Retained Earnings : ₩-24,381 Mil (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Adbiotech Co Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Adbiotech Co's retained earnings for the quarter that ended in Dec. 2024 was ₩-24,381 Mil.

Adbiotech Co's quarterly retained earnings declined from Jun. 2024 (₩-22,534 Mil) to Sep. 2024 (₩-23,621 Mil) and declined from Sep. 2024 (₩-23,621 Mil) to Dec. 2024 (₩-24,381 Mil).

Adbiotech Co's annual retained earnings declined from Dec. 2022 (₩-13,574 Mil) to Dec. 2023 (₩-16,431 Mil) and declined from Dec. 2023 (₩-16,431 Mil) to Dec. 2024 (₩-24,381 Mil).

Adbiotech Co Retained Earnings Historical Data

The historical data trend for Adbiotech Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adbiotech Co Retained Earnings Chart

Adbiotech Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Retained Earnings

Get a 7-Day Free Trial

-13,606.00

-16,270.46

-13,574.18

-16,431.38

-24,381.35

Adbiotech Co Quarterly Data
	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Retained Earnings	Get a 7-Day Free Trial													-16,431.38	-20,676.67	-22,533.68	-23,621.07	-24,381.35

Adbiotech Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Adbiotech Co (XKRX:179530) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Adbiotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adbiotech Co Ltd (XKRX:179530) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

N/A

Address

39, Geodudanji 1-gil, Dongnae-myeon, Gangwon-do, Chuncheon, KOR, 24398

Website

http://www.adbiotech.com

Adbiotech Co Ltd is a life science company. It develops a vaccine and antibiotic-friendly substances such as IgY, Immunoglobulin in Yolk for human, animal and fish oral antibody products, and functional cosmetics and food additives. The company aim to develop Helico IgY, Cholesterol IgY, and Ulcerative Colitis natural product medicines.

Adbiotech Co Headlines

No Headlines